Shin Takahashi Selected Research

Shin Takahashi Research Topics

Disease

32	Neoplasms (Cancer) 01/2024 - 01/2002
19	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 07/2005
10	Death (Near-Death Experience) 03/2024 - 01/2019
5	Carcinoma (Carcinomatosis) 01/2008 - 12/2004
4	Carcinogenesis 09/2022 - 12/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2004
3	Breast Neoplasms (Breast Cancer) 11/2021 - 02/2008
3	Disease Progression 03/2019 - 01/2018
2	Hemorrhagic Fever with Renal Syndrome (HFRS) 03/2024 - 10/2022
2	Neutropenia 02/2024 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 12/2022 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2020
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2019 - 07/2006
2	Fistula 01/2018 - 01/2015
1	Polymorphic catecholergic ventricular tachycardia 04/2024
1	Generalized Epilepsy 04/2024
1	Leukopenia 02/2024
1	Adenocarcinoma 02/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2024
1	Hiccup (Hiccups) 01/2023
1	COVID-19 01/2023
1	Pain (Aches) 06/2022
1	Cancer Pain 06/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Pseudomyxoma Peritonei 04/2020

Drug/Important Bio-Agent (IBA)

10	Irinotecan (Camptosar)FDA LinkGeneric 02/2024 - 01/2012
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 01/2014
8	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 07/2005
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
5	Flame Retardants (Fire Retardants)IBA 03/2024 - 03/2013
5	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 06/2023 - 07/2019
5	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2019
3	Environmental Pollutants (Pollutants, Environmental)IBA 03/2024 - 01/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 07/2006
3	Gemcitabine FDA Link 02/2024 - 01/2017
3	Cetuximab (Erbitux)FDA Link 04/2023 - 01/2014
3	Halogenated Diphenyl EthersIBA 01/2023 - 05/2020
3	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2010
2	EstersIBA 03/2024 - 10/2022
2	OrganophosphatesIBA 03/2024 - 10/2022
2	polyurethane foamIBA 06/2023 - 01/2019
2	Therapeutic UsesIBA 09/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 02/2008
2	ParaffinIBA 04/2021 - 12/2015
2	Formaldehyde (Formol)FDA Link 04/2021 - 12/2015
2	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2018
2	Polychlorinated Biphenyls (PCBs)IBA 08/2020 - 05/2020
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 12/2004
2	afliberceptIBA 11/2019 - 03/2019
2	AntibodiesIBA 01/2019 - 07/2003
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2017 - 01/2010
2	Heparin (Liquaemin)FDA LinkGeneric 03/2017 - 01/2010
2	Docetaxel (Taxotere)FDA Link 01/2017 - 01/2016
2	2-toluenesulfonamide (OTS)IBA 01/2017 - 12/2009
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 04/2024
1	AlbuminsIBA 02/2024
1	Levofloxacin (Levaquin)FDA Link 02/2024
1	Cytotoxins (Cytolysins)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	LuciferasesIBA 12/2022
1	SiliconesIBA 12/2022
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 10/2022
1	decabromodiphenyl ethaneIBA 10/2022
1	Opioid Analgesics (Opioids)IBA 06/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	CateninsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Stearoyl-CoA DesaturaseIBA 01/2022
1	Estrogen ReceptorsIBA 11/2021
1	HydrocarbonsIBA 10/2021
1	Particulate MatterIBA 10/2021
1	LigandsIBA 10/2021
1	Dust (House Dust)FDA Link 09/2021
1	Benzo(a)pyreneIBA 09/2021
1	Trifluridine (Viroptic)FDA LinkGeneric 01/2021
1	trifluridine tipiracil drug combinationIBA 01/2021
1	AfatinibIBA 12/2020
1	DioxinsIBA 05/2020
1	OilsIBA 05/2020
1	SoilIBA 03/2020
1	Interleukin-8 (Interleukin 8)IBA 11/2019
1	Carrier Proteins (Binding Protein)IBA 11/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2019
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2019
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2019
1	TenascinIBA 11/2019

Therapy/Procedure

24	Therapeutics 02/2024 - 07/2006
18	Drug Therapy (Chemotherapy) 02/2024 - 08/2007
2	Glycemic Control 01/2024 - 01/2024
2	Precision Medicine 06/2023 - 01/2023
2	Catheters 01/2018 - 01/2014
2	Combination Drug Therapy (Combination Chemotherapy) 01/2016 - 09/2015
2	Pancreaticoduodenectomy 01/2008 - 01/2007
1	Immunotherapy 01/2022